VORAXAZE

Swiss trademark · 637839 · Word mark · In force

Register entry

Registration number
637839
Application number
62736/2012
Status
In force
Type
Word mark
Filed
Nov 1, 2012
Registered
Dec 12, 2012
Published
Dec 12, 2012
Protected until
Nov 1, 2032
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate und Substanzen; veterinärmedizinische Präparate und Substanzen; pharmazeutische Präparate, die Methotrexat-Gegenmittel enthalten; pharmazeutische Präparate zur Verwendung in der Chemotherapie und bei Autoimmunerkrankungen; pharmazeutische Präparate zur Verwendung in der Regulierung der Toxizität von Therapeutika; pharmazeutische Präparate zum Abbau von Therapeutika-Konzentrationen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 5, 2023

    Holder’s address changed

    Owner
    Protherics Medicines Development Limited, 5 Fleet Place, London, EC4M 7RD, United Kingdom → Protherics Medicines Development Limited, C/O Collyer Bristow LLP, 140 Brompton Road, Knightsbridge, London SW3 1HY, United Kingdom

    Published in Swissreg on 05.07.2023

  2. Aug 24, 2022

    Agent removed

    Representative
    A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich (removed)

    Published in Swissreg on 24.08.2022

  3. Aug 8, 2022

    Renewed

    Published in Swissreg on 08.08.2022

  4. Apr 16, 2014

    Agent’s address changed

    Representative
    A. W. Metz & Co. AG, Hottingerstrasse 14, 8024 Zürich → A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 16.04.2014

  5. Dec 12, 2012

    Registered

    Published in Swissreg on 12.12.2012

Parties

Holder

Protherics Medicines Development Limited

C/O Collyer Bristow LLP 140 Brompton Road Knightsbridge, London SW3 1HY, GB

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.